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Summary 
We have examined whether T  cell stimulation by direct or indirect pathways contributes to al- 
loantibody production by B cells after major histocompatibility complex (MHC)-disparate skin 
graft rejection in mice. Experiments were performed using normal mice, MHC class II-defi- 
cient mice, MHC class II-deficient mice with an intact peripheral CD4 + cell population (due 
to expression of class II antigens only on thymic epithelium), mice lacking the cytoplasmic tail 
of their MHC class II antigens, and mice depleted of CD4 + cells by anti-CD4 monoclonal an- 
tibody treatment. Depletion of recipient CD4 + cells reduced alloantibody production to barely 
detectable levels. Absence of donor MHC class II antigens did not affect the production of ei- 
ther immunoglobulin (Ig)M or IgG antibodies directed at class I alloantigens. Absence of recip- 
ient MHC class II antigens, however, led to production of only IgM but not IgG antibodies, 
even if the recipients had an intact CD4 + cell population. Absence of the cytoplasmic tail of 
the recipient's MHC class II antigens led to the production of slightly reduced amounts of IgG 
antibody. These findings indicate that (a) CD4 + cells are essential  helper cells for B cell alloan- 
tibody production; (b) production of IgM alloantibody can occur with help from CD4 + cells, 
which recognize either donor class II antigens or modified recipient class II antigens; (c) isotype 
switching from IgM to IgG alloantibody requires help from CD4 + cells activated by antigens 
presented by recipient MHC class II molecules; and (d) the cytoplasmic domain of the recipient 
MHC class II molecules may be involved in the mechanism that leads to isotype switching by 
B cells. Thus, there are two levels of CD4-mediated help available for B cells responding to al- 
loantigens: one (involving a noncognate interaction) can produce B cell activation, and a sec- 
ond (involving a cognate interaction) is required for differentiation and IgG alloantibody pro- 
duction. 
T 
cells help B  cells to produce antibody against  T  cell- 
dependent antigens  and to switch the  isotype of the 
antibody produced from IgM to other isotypes, including 
IgG.  This T-B  cell interaction has  been characterized by 
studies  of immune  responses to hapten-carrier conjugates 
and shown to be MHC class II antigen restricted (1, 2). In 
the case  of allogeneic tissue  transplantation,  helper T  cells 
can be activated directly by class II antigens expressed on 
donor APC,  or indirectly by peptides  of donor antigens 
presented by self class II molecules on recipient APC. Two 
different schemes have therefore been proposed by which 
T-B cell collaboration might occur for B  cell responses to 
class I alloantigens expressed on foreign cells (Fig.  1). First, 
the B cells could be stimulated by class I antigens on donor 
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APC,  and  the  CD4 + helper cells  could be  stimulated by 
MHC class II antigens on the same cells. This would bring 
the T  and B  cells into physical proximity, but without an 
interaction between  the  T  cell receptor and  the  B  cell's 
class II antigens. Thus, this would be a "noncognate" inter- 
action.  Second, the B  cells  could be stimulated by class I 
antigens on donor cells, and the CD4 + cells could be stim- 
ulated by foreign peptides presented by class II antigens on 
the recipient's own APC. These CD4 + cells could then in- 
teract with the B  cells in a "cognate" fashion, achieved by 
the class II-restricted T  cell recognition of foreign peptides 
presented by the B cells. 
Using mice that lack MHC class II antigens, as either do- 
nors or recipients of MHC-disparate  skin grafts,  we have 
examined which of these pathways of interaction leads  to 
the production ofalloantibody. The results demonstrate the 
importance of the indirect pathway in allogeneic responses 
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to provide help for B cell anti-class I alloantibody production.  (A) B cells 
could be stimulated by class I antigens on the surface of donor APC, and 
CD4 + helper cells could be stimulated directly by the donor class II anti- 
gens on the same APC. This would bring the T and B cells into physical 
contact but would not allow a cognate  interaction  between the respon& 
ing T  cell receptor with the MHC class II molecule of the B cell. (B) B 
cells could be stimulated by antigens on donor cells, and CD4 + cells could 
be stimulated  indirectly  by foreign  peptides  presented  by the recipient's 
APC. These CD4 + cells could then provide help for the B cells by a cog- 
nate interaction  with the B cell's own class lI antigens. 
in  vivo,  and  they  also  reveal  that  CD4 +  cells can  provide 
two levels of help  for B  cells,  depending  on  the  nature  of 
the T-B  cell interaction. 
Materials and Methods 
Mice.  Male  BALB/cByJ  (BALB/c)  (H-2  d)  and  C57B1/6J 
(B6)  (H-2  b)  mice were purchased  from The Jackson  Laboratory 
(Bar Harbor,  ME).  Mice lacking MHC  class  II antigens  (class  II 
deficient),  mice expressing MHC  class  II antigens  only on  their 
thymic epithelium (CD4 + class II deficient), and mice expressing 
class  II  antigens  with  truncated  cytoplasmic  domains  (tailless), 
were bred in our laboratories. 
The  genotype  and  phenoWpe  of mice lacking MHC  class  II 
antigens  have  been  previously  described  (3).  For  these  experi- 
ments, mice from the third generation backcross of(B6 ￿  129)F1 
to B6 mice were used.  Prior characterization of the class II-defi- 
cient mice has  shown  that  no  class  II antigen expression  can  be 
detected.  These mice also show a substantial  depletion of CD4 + 
peripheral  T  cells,  although  3-5%  of the peripheral  Thyl §  cells 
are CD4 +. Class II-deficient mice have normal levels and devel- 
opment of B  cells since T  cell-independent B  cell responses oc- 
cur in vivo, and T  cell-dependent B  cell activation can occur in 
vitro, despite the absence of MHC class II antigens (4). 
Mice expressing MHC  class  II antigens  only on  their thymic 
epithelium  were  generated  by  breeding  class  lI-deficient  mice 
with a C57B1/6-transgenic strain (gift of Dr. D. Lo, Scripps Re- 
search  Institute,  La Jolla, CA), which expresses the EIx transgene 
only on thymic epithelium (5). These mice are MHC class 1I de- 
ficient on all cells other than thymic epithelium, but they do have 
normal numbers of peripheral CD4 + cells,  which proliferate in an 
allo MLR in vitro (Laufer, T., unpublished observations). 
Mice that express a class 1I A b molecule with a truncated cyto- 
plasmic domain were generated by mating class II-deficient mice 
with mice expressing an A~  b transgene that lacks 13 of its 18 cyto- 
plasmic  domain  residues.  The  initial  characterization  of these 
mice has  been previously reported,  demonstrating  that  they de- 
velop normal levels and functions ofCD4 + T  cells and have nor- 
mal B cell responses to environmental pathogens (6). 
CD4-depleting Therapy.  To deplete CD4 + cells in vivo, tbymec- 
tomized B6  mice were treated  with  0.1  ml of GK1.5  ascites  on 
days  6,  3,  and  1  before  skin  grafting.  This  technique  depletes 
>98% ofCD4 + cells for several weeks (7). 
Skin Grafting.  Trunk skin grafts  were placed oi1 mice accord- 
ing to the technique of Billingham and Medawar (8).  Mice were 
anesthetized with chloral hydrate supplemented with ether. After 
rejecting their grafts,  mice were  then bled from the  retroorbital 
plexus and subsequently boosted with 10  s splenocytes of the same 
donor  type  by  intraperitoneal  injection  at  weekly  intervals  for 
3 wk.  Sera  used  for  the  experiments  shown  were  all  obtained 
3 wk afi:er placing the skin grafts. 
Antibody-mediated  Complement-dependent  Cytotoxicity  Assay. 
These assays were performed in two stages with minor modifica- 
tions from the technique previously described (9).  Sera were heat 
inactivated at 56~  for 30 min and stored at  -20~  until tested. 
10 s 51Cr-labeled mouse splenocytes of donor type were incubated 
with  serially diluted  sera  in  a  final  volume of 50  txl  in  U-bot- 
tomed  wells for  15  rain  at  37~  Cells  were  washed  with  me- 
dium,  pelleted,  resuspended,  and incubated  with  rabbit  comple- 
ment  (C-6 Diagnostic,  Inc.,  Mequon,  WI)  at  a  final dilution  of 
1:12  for 30  min at 37~  Cells were pelleted and  100  Ixl of the 
supernatant harvested and counted on a gamma counter (Gamma 
4000;  Beckman  Instruments,  Inc.,  Fullerton,  CA). Percentage  of 
lysis was calculated by comparison to the S~Cr release obtained us- 
ing a  rabbit  anti-mouse  lymphocyte serum made in  our labora- 
tory.  To inactivate antibody of the  IgM isotype,  50  ~xl of serum 
was incubated with 5 Ixl of 1 M  2-ME for 30 min at 37~  before 
the assay. 
Antibody  Staining and Flow Cytometric Analysis.  Thymic T  cells 
were  used  as  targets  for flow cytometric analysis  of alloantibody 
production.  FACS  |  medium contained PBS,  1% BSA, and 0.1% 
sodium azide. 3  X  l0  s cells were added to each well of a 96  well 
U-bottomed plate. Mouse FcgIItL was blocked with 20 txl of 2.4 
G2, a rat anti-mouse FcglIR mAb, by incubating with the cells at 
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FACS  |  medium. 25 Ixl of serum from mice that had rejected skin 
grafts was then added at  1:2 and 1:4 dilutions to the test wells 
and incubated at 4~  for 30 min. Cells were again washed twice 
with  100  Ixl FACS  |  solution. FITC-conjugated rat anti-mouse 
antibodies against [gM,  IgG1  (Zymed Laboratories, Inc.,  South 
San Francisco, CA), IgG2a, or IgG2b (Baxter Healthcare Corp., 
Mundelein, IL) were then added and incubated with the cells at 
4~  for  30  rain.  Cells were  again washed  twice  with  100  Izl 
FACS  |  solution, fixed with 2% paraformaldehyde, and analyzed 
using a FACScan flow cytometer (Becton Dickinson Immunocy- 
tometry Systems, Mountain View, CA). 
Results 
To  generate  alloantibody production,  skin  grafts  from 
MHC-disparate allogeneic donors were placed on recipient 
mice. All skin grafts were rejected within 15 d, and neither 
treatment with  anti-CD4  mAb nor  the  absence  of MHC 
class II antigens on the donor or recipient altered the time 
to  rejection when  compared with normal controls.  These 
findings are in keeping with previously reported data (9-11). 
Sera from recipient mice were tested 3 wk after grafting for 
the presence of alloantibody, as shown in Fig. 2. Additional 
sera from later time points were also tested, but the results 
in  all  groups  were  not  different  in  character  from  those 
shown. 
Normal Mice.  Normal  recipients of normal  MHC-dis- 
parate  skin  grafts  produced  antidonor  cytotoxic  alloanti- 
body of IgM isotype and then increasing titers of IgG iso- 
type.  The  levels  at  3  wk  are  shown  in  Fig.  2  A.  The 
antibodies in these sera were shown to be directed at class I 
alloantigens by  testing  them  on  targets  from  MHC-con- 
genic strains (data not shown). 
CD4-depleted Redpients.  Recipients treated with thymec- 
tomy  and  anti-CD4  mAb  before  skin  grafting  produced 
very low or undetectable levels of cytotoxic alloantibody, 
and there was  no  switch to  IgG isotype, as shown  in Fig. 
2 B. This requirement for CD4 + cells to generate alloanti- 
body production is in agreement with previously reported 
data (9). 
MHC Class II-deficient Mice as Donors.  When MHC  class 
II--deficient mice were used as skin graft donors for normal 
recipients, both IgG and lgM alloantibody production was 
equivalent to normal controls, as shown in Fig. 2  C. Thus, 
CD4 +  cells stimulated only through  the indirect pathway, 
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Figure 2.  Cytotoxic aUoantibody levels in response 
to skin grafting. Sera  were obtained 3 wk after grafting, 
and alloantibody levels were determined in a 5tCr re- 
lease antibody-mediated complement-dependent cyto- 
toxicity assay using mouse splenocytes of donor type as 
targets. IgM combined with lgG levels were measured 
using untreated sera. IgG levels alone were obtained af- 
ter treatment of sera with 2-ME.  The data presented 
represent means of lysis  by sera from at least four mice 
in each panel shown. (A) B6 mice (H-2  b) received skin 
grafts from  MHC-disparate  BALB/c  (H-2  d)  donors. 
Almost identical results were obtained when BALB/c 
recipients received B6 skin grafts (data not shown). (B) 
CD4-depleted  B6  mice  received  skin grafts from 
BALB/c donors.  (C)  Normal BALB/c recipients re- 
ceived skin grafts from B6 MHC class II-deficient do- 
nors. (D)  B6  MHC  class lI-deficient recipients re- 
ceived skin grafts from BALB/c donors. (E) B6 MHC 
class II-deficient recipients expressing class II antigens 
only on their thymic epithelium received grafts from 
BALB/c donors. (F) B6 class  II-deficient mice express- 
ing a class II transgene that  encodes class II antigens 
lacking their  cytoplasmic tail received BALB/c  skin 
grafts. 
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efficiently for alloantibody production. 
MHC  Class II-deficient Mice as Recipients.  MHC  class  II- 
deficient  mice  that  received  normal  skin  grafts  produced 
cytotoxic  alloantibodies,  but  in  reduced  titers  when  com- 
pared with normal controls.  The antibody produced was of 
IgM  isotype  only,  and  no  IgG was  found  in  these  recipi- 
ents,  both  in  assays  for  antibody-mediated  complement- 
dependent  cytotoxicity as shown in Fig.  2  D  and by FITC 
anti-antibody  staining  (data not shown). 
Although  the donor skin grafts in these experiments  ex- 
pressed class  II antigens that could stimulate CD4 + cells di- 
rectly, the recipients had two defects that could account for 
their reduced  antibody production:  they lacked class  II an- 
tigens  on  their  own  cells  for use  in  the  indirect  pathway, 
and they also had severely reduced  numbers  of CD4 + cells 
to provide help  for B  cells.  Therefore,  to  test whether  di- 
rect  stimulation,  in  the  absence  of the  indirect  pathway, 
could provide help for B  cells, we needed recipients with- 
out class II antigen expression but that had normal numbers 
ofCD4 + cells. 
Mice Expressing  Class  II Antigens  Only  on  Thymic Epithe- 
lium as Recipients.  Class  II-deficient  mice  that  express  a 
class  II transgene  only on  thymic  epithelium  develop  nor- 
mal numbers of mature CD4 + cells but still lack class  II an- 
tigens on their peripheral APC.  When  these mice were re- 
cipients of normal skin grafts, they produced only moderate 
titers of total cytotoxic antibody,  all of which  was again of 
IgM isotype, as shown in Fig. 2  E. These results were con- 
sistent in antibody-mediated  complement-dependent  assays 
and  in  assays  using  FITC  anti-antibody  staining  (data  not 
shown).  Thus,  in the presence of direct but in the  absence 
of indirect  T  cell stimulation,  CD4 + cells can provide help 
for B  cells, but only for a limited response. 
Mice with  Tailless  Class 1I Molecules  as Recipients.  Finally, 
recipients  lacking  the  intracytoplasmic  domain  of  their 
MHC  class I1 antigens were found to produce  alloantibody 
that included both IgM and IgG isotypes. However, in two 
separate  experiments,  there  was  a  slight  reduction  in  the 
IgG  component  of the  total  cytotoxic  antibody  response 
compared with normal animals (Fig.  2  F). 
Discussion 
The primary purpose of these experiments was to deter- 
mine the answer to a long-standing question in transplanta- 
tion  immunology:  whether  donor  class  II antigens  stimu- 
late  helper  CD4 +  cells  for  alloantibody  production  by 
direct recognition,  or whether recipient  class  II molecules, 
presenting  peptides  of donor  antigens,  stimulate  a  helper 
response  through  what has been termed  the  indirect  path- 
way. We expected that the indirect pathway would be suf- 
ficient,  since  this  is  the  mechanism  for a  normal  immune 
response. We also expected,  based on previous studies,  that 
both  IgM  and  IgG alloantibody  responses  after skin  trans- 
plantation  would  depend  on the presence of CD4 + T  cells 
(9).  Finally,  we  were  not  surprised  that  stimulation  of 
CD4 +  cells  only  by  the  nonphysiologic,  direct  pathway 
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was  unable  to  stimulate  IgG  antibody  production.  These 
experiments,  therefore,  settle  the  issue  in  transplantation 
immunology,  at least as  far as  the  response  to  class  I  anti- 
gens  on  skin  grafts.  In  doing  so  they  also  provide  further 
evidence that the so-called indirect pathway in transplanta- 
tion does play a role in the immune response to foreign tis- 
sues and that this pathway is actually critical as far as alloan- 
tibody production  is concerned. 
The result we did not expect (which was, therefore, par- 
ticularly interesting)  was that CD4 + cells stimulated  by the 
direct  pathway  alone  would  allow  an  intermediate  B  cell 
response, including  IgM but not  IgG alloantibody produc- 
tion.  This result is of interest beyond the field of transplan- 
tation immunology since it indicates that B  cells are suscep- 
tible  to  two  levels  of help  for  antibody  responses.  When 
CD4 + cells are stimulated in a way that links them in phys- 
ical proximity to B  cells, their helper factors can apparently 
activate  the  B  cells  partially,  allowing  the  IgM  response. 
However, apparently only when the CD4 + cells are stimu- 
lated in a way that provides both linkage and a cognate in- 
teraction  through  the  class  II molecules of the B  cells does 
the helper response signal the B  cells to switch to IgG pro- 
duction.  Only a  transplantation  experiment,  especially one 
involving  the  recently  available  class  II  knock-out  mice, 
would  allow us to see  this distinction  in vivo.  In no  other 
way could one bring B  cells,  recognizing a foreign protein 
antigen,  into a physical but noncognate linkage with CD4 § 
helper  cells  than  to  stimulate  the  CD4 +  cells  with  alloge- 
neic  class  II molecules while  eliminating  the  class  II mole- 
cules  of the recipient's  own APC.  Thus,  these  transplanta- 
tion experiments provide new insight into the mechanisms 
of normal B  cell physiology. 
Our  experiments  have  not  yet  proven  that  a  physical 
linkage  is  required  between  the  CD4 +  cells,  stimulated  by 
donor  class  II antigens,  and the B  cells that respond to do- 
nor  class  I  alloantigens.  It seems likely that  such  linkage  is 
necessary, given the many previous experiments  indicating 
that linkage between T  and B  cells is a physiologic require- 
ment in vivo  (1,  2,  12).  However,  to  demonstrate  this re- 
quirement  in  our  model  we  will  need  to  determine 
whether  B  cells  from  mice  lacking  their  own  peripheral 
class  II  antigen  expression  can  respond  to  donor  alloanti- 
gens,  such  as  Thyl,  which  are  not  expressed  on  the  same 
cells  that  express  the  class  II  alloantigens  that  stimulate 
CD4 + helper cells. 
It is also not clear from our experiments exactly why the 
cognate interaction between T  and B  cells, through  recog- 
nition  of the B  cells' class  II antigens,  should be important 
in the switch to IgG antibody production.  One explanation 
is that such an interaction is simply the best way to achieve 
the closest possible physical proximity between helper cells 
and  B  cells.  The  other  is  that  the  class  II molecules  of B 
cells are involved in the signaling that allows conversion to 
an IgG response.  Previous  in vitro  studies  with  transfected 
cell lines have suggested that the  cytoplasmic tail of class  II 
molecules  is  necessary  for the  expression  of costinmlatory 
molecules  (13-16),  but  subsequent  studies  with  the  same 
transgenic  mice  used  in  our  experiments,  which  express 
Alloantibody Production only  class  II  molecules  with  a  truncated  intracytoplasmic 
domain,  have indicated  that they produce normal IgG re- 
sponses to nominal antigens,  although they appear to have 
a  quantitative  defect in  their  ability to present  peptides  of 
foreign  proteins  (6).  In  our  experiments  we  found  that 
both IgM and IgG alloantibody responses were fundamen- 
tally intact in the mice lacking their class II intracytoplasmic 
domain, although the IgG response appeared to be weaker 
in several experiments.  Thus,  our results  are  consistent ei- 
ther with the interpretation  that slightly diminished presen- 
tation  of peptides  by  these  truncated  class  II  molecules 
weakens  the  physical association  of T  and B  cells,  or that 
the absence of the cytoplasmic portion of the B  cells' class 
II molecules  impairs  the  signaling  that  leads  to  IgG  con- 
version. 
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